查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球萤光透视设备市场
市场调查报告书
商品编码
1166519

2022-2029 年全球萤光透视设备市场

Global Fluoroscopy Equipment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2022-2029)，荧光检查的市场规模预计将以 5.22% 的复合年增长率增长。

透视是一种医学诊断成像设备，它以与 X 射线电影相同的方式在监视器上显示 X 射线图像。 它使用 X 射线实现物体内部的实时动画，类似于 X 射线照相和计算机断层扫描。 它可用于心臟和肠道疾病的诊断（病因调查）。 它还用作植入物和注射等治疗以及整形外科手术的指南。 您可以查看器官、关节、肌肉和骨骼的内部。

市场动态

介入放射学手术数量的增加、微创手术数量的增加、技术进步的不断增加以及心血管疾病患病率的上升是全球荧光检查市场的主要驱动力。是一些关键的市场驱动力。

荧光成像设备的最新创新有望推动市场增长。

ControlRad, Inc. 是一家私营医疗技术公司，专注于大幅减少荧光镜引导手术过程中不必要的辐射暴露，该公司于 2019 年 5 月推出了经 FDA 批准的 ControlRad Trace。 ControlRad Trace 是唯一可以集成到现有移动 C 形臂中以减少任何荧光镜成像程序中的辐射的技术。 此外，Siemens Healthmeyers 旗下的 Corindus 公司在其 2020 年 5 月号的论文《循环：心血管介入》中报告说，使用 CorPath GRX 系统的机器人 PCI 可以改善手动 PCI，据称与相比，机器人 PCI 可将患者的辐射暴露减少 20% PCI。 因此，上述因素预计将在预测期内推动市场。

设备的高成本预计会阻碍市场增长。

然而，由于其先进的功能和特点，移动系统也很昂贵，成本超过20万美元。 先进的移动装置配备了 20KW 发电机，使其能够穿透緻密组织。 GE Healthcare 的昂贵产品包括 OEM 9900 Elite 和 GM Imaging 的视觉 RFD，它们配备了大图像显示器并能够进行准确的图像评估。 除了高昂的设备成本外，打印机和 DICOM 盒等直接成本也会增加总拥有成本。 因此，设备的使用寿命比平均寿命长。 因此，预计上述因素将在预测期内阻碍市场。

COVID-19 影响分析

预计 COVID-19 的爆发将影响 C 型臂市场。 由于 COVID-19 而推迟，通常选择性图像引导程序使用 C 臂。 随着对支持 COVID-19 治疗的设备（例如呼吸机）的关注度越来越高，医院可能在此次大流行期间削减了昂贵的资本支出。 例如，根据英国外科杂誌发表的一项研究，预计 2020 年全球约有 2840 万例择期手术将被取消或推迟。 该预测基于 COVID-19 对医院服务造成的为期 12 週的高峰中断。 COVID-19 大流行迫使印度取消或推迟了超过 580,000 项计划中的手术。 但是，为了容纳 COVID-19 阳性且需要手术的患者，欧洲泌尿外科协会建议创建配备特殊设备的手术室。 这个房间需要为放射科医师和医疗保健专业人员提供移动式 C 型臂 X 射线透视系统。 因此，鑑于 COVID-19 病例数量的增加以及对整个地区医疗保健系统的重大影响，预计市场将在预测期内保持目前稳定的增长率轨迹。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 荧光成像的最新创新有望推动市场增长。
    • 约束因素
      • 设备的高成本预计会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 搬运工的五种力量
  • 供应链
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 透视设备
  • 固定式 C 型臂
  • 移动全尺寸手臂
  • 移动式迷你 C 型臂

第八章应用

  • 诊断应用
    • 心脏病学
    • 泌尿科/肾臟科
    • 神经血管
    • 其他
  • 手术
    • 整形外科/外伤外科
    • 神经外科
    • 心血管外科
    • 消化外科
    • 其他

第 9 章最终用户

  • 医院
  • 诊断中心
  • 门诊手术中心
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第12章公司简介

  • Siemens Healthcare
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • GE Healthcare
  • Philips Healthcare
  • Carestream Health, Inc.
  • Canon Medical Systems
  • Hitachi Medical Systems
  • Shimadzu Corporation
  • Ziehm Imaging GmbH
  • Fujifilm Medical Systems
  • Lepu Medical Technology

第13章 全球萤光透视装置市场-DataM

简介目录
Product Code: DMMI1248

Market Overview

Fluoroscopy Equipment Market size was valued around US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 5.22% during the forecast period (2022-2029).

Fluoroscopy equipment is medical imaging equipment that displays the X-ray image on a monitor, the same as an X-ray movie. It uses X-rays to achieve real-time moving images of the inside of an object, like X-ray radiography and computed tomography. Fluoroscopy can be used to diagnose (determine the cause of) a health problem such as heart or intestinal disease. It is also used to guide treatments such as implants or injections and in orthopedic surgery. It allows the doctor to look inside organs, joints, muscles, and bones.

Market Dynamics

Increasing number of interventional radiology procedures, the rising number of minimally invasive procedures, increased technological advancements, and the growing prevalence of cardiovascular diseases are some of the key market drivers of Global Fluoroscopy Equipment Market.

Latest innovations in fluoroscopic imaging equipment is expected to drive market growth.

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, launched the FDA-approved ControlRad Trace in May 2019. ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure. Moreover, Corindus, a Siemens Healthineers company, announced in the published article "Circulation: Cardiovascular Interventions" in May 2020 states that robotic PCI with the CorPath GRX System reduces patient radiation exposure by 20% compared to manual PCI while increasing fluoroscopy time and contrast utilization. Thus, from the above-mentioned factors, the market is expected to drive in the forecast period.

The high cost of equipment is expected to hamper the market growth.

However, due to their advanced features and functionalities, mobile systems also have a high cost, which is more than USD 200,000. Advanced mobile units have 20KW generators attached, allowing them to penetrate dense tissues. The costliest ones manufactured by GE Healthcare include OEM 9900 Elite and Ziehm Imaging's vision RFD, which include large image displays to enable accurate image evaluation. Apart from the high equipment cost, there are other direct expenses for printers and DICOM boxes which increase the total cost of ownership. Due to this, the usage of the equipment is extended beyond its average life. Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to have an effect on the market for C-arms. Image-guided procedures, which are typically elective and were delayed because of COVID-19, use C-arms. Due to their increased focus on ventilators and other COVID-19 treatment-supporting equipment, hospitals may have refrained from investing in expensive capital equipment during the current pandemic. For instance, according to the study published in the British Journal of Surgery, approximately 28.4 million elective surgeries worldwide were anticipated to be canceled or postponed in 2020. This prediction was based on 12 weeks of peak hospital service disruption caused by COVID-19. The COVID-19 pandemic has forced the cancellation or postponement of more than 580,000 scheduled surgeries in India. However, to handle COVID-19-positive patients require surgery, it is recommended by the European Association of Urology that a specially furnished operating room should be created. This room will require a mobile C-arm fluoroscopic X-ray system for radiology and healthcare professionals. Therefore, it is anticipated that the market will maintain its current steady growth rate trajectory during the forecast period, considering the rising cases of COVID-19 and its significant impact on healthcare systems throughout the region.

Segment Analysis

Fluoroscopy devices segment is expected to hold the largest market share in fluoroscopy equipment

The fluoroscopy devices segment accounted for the largest market share in 2021. This is owing to the usage of a wide array of procedures such as image-guided biopsy, angiography, and discography. In addition to this, fluoroscopes are increasingly used in previously unexplored applications such as nondestructive testing of medical devices and quality assurance. The increasing number of recent FDA approvals is expected to accelerate market growth. For instance, on August 4, 2022, Xoran Technologies received FDA 510(k) clearance for TRON, a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system. As of February 21, 2019, Agfa Healthcare's DR 800 multipurpose digital radiography (DR) imaging system with tomosynthesis received FDA 510(k) clearance. The DR 800 provides a single solution for advanced clinical applications, multi-slice imaging, fluoroscopy, radiography, and radiography, supporting radiology in value-based care organizations with greater adaptability, functionality, and effectiveness. Thus, from the above-mentioned factors, the market segment is accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global fluoroscopy equipment

North America region accounted for the largest market share in 2021. The increasing prevalence of cardiovascular and orthopedic surgeries, high standards of healthcare infrastructure, the high frequency of diagnostic examination, the rising geriatric population, and the increasing prevalence of chronic diseases in the U.S. are the factors to drive the market in the forecast period. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups in the U.S. Cardiovascular disease claims one life in the U.S. every 34 seconds. 1 in 5 deaths in the U.S. in 2020 was caused by heart disease, which affected approximately 697,000 people. Additionally, in 2020, adults under 65 years old accounted for about 2 in 10 deaths from CAD.

Moreover, because of its developed healthcare system, the U.S. has the largest installed base of C-arms globally. Additionally, all C-arms are replaced following the replacement schedule due to the strict regulations in the U.S., according to the healthcare regulatory authorities, which guarantees that the new C-Arm sales in the country are consistent. Thus, from the above factors, the North America region is expected to hold the largest market share in the forecast period.

Global Fluoroscopy Equipment Market- Competitive Landscape

Major key players in the fluoroscopy equipment market include Siemens Healthcare, GE Healthcare, Philips Healthcare, Carestream Health, Inc., Canon Medical Systems, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Fujifilm Medical Systems and Lepu Medical Technology.

For instance, on January 13, 2021, the FDA approved Siemens Cios Flow mobile C-arm in the U.S. It is designed to be a general-purpose C-arm that can be easily used in various cases and is intended for orthopedics, vascular surgery, trauma, spinal surgery, and other fields.

Shimadzu Corporation:

Overview:

Shimadzu Corporation is a Japanese public KK company that manufactures measuring devices, medical equipment, and precision instruments. In order to use advances in science and technology to make society more convenient, secure, and safe, the company operates in four segments: analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Shimadzu Scientific Instruments (SSI) is the Shimadzu Corporation's American subsidiary (Kyoto, Japan). SSI was founded in 1975 as a distribution hub that offered labs and service providers in the Americas analytical solutions. Shimadzu U.S.A. Manufacturing provides HPLC, GC-MS/MS, LC-MS/MS, and other high-tech products to the U.S. market through its ten regional offices strategically positioned across the country. These offices are staffed with experienced technical specialists, service and sales engineers, and a state-of-the-art Customer Training and Education Center.

Product Portfolio:

OPESCOPE ACTENO: It is a mobile C-arm Imaging System whose main applications are X-ray fluoroscopy and radiography during surgery. Lock mechanisms allow individual movement locking, ensuring quick and accurate positioning.

The global fluoroscopy equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Latest innovations in fluoroscopic imaging are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of equipment is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Fluoroscopy Devices*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Fixed C-Arms
  • 7.4. Mobile Full Size C-Arms
  • 7.5. Mobile Mini C-Arms

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diagnostic Applications
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth
    • 8.2.3. Cardiology *
    • 8.2.4. Urology and Nephrology
    • 8.2.5. Neurovascular
    • 8.2.6. Others
  • 8.3. Surgical Applications
    • 8.3.1. Orthopedic & Trauma Surgeries
    • 8.3.2. Neurosurgeries
    • 8.3.3. Cardiovascular Surgeries
    • 8.3.4. Gastrointestinal Surgeries
    • 8.3.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Centers
  • 9.4. Ambulatory Surgery Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Siemens Healthcare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. GE Healthcare
  • 12.3. Philips Healthcare
  • 12.4. Carestream Health, Inc.
  • 12.5. Canon Medical Systems
  • 12.6. Hitachi Medical Systems
  • 12.7. Shimadzu Corporation
  • 12.8. Ziehm Imaging GmbH
  • 12.9. Fujifilm Medical Systems
  • 12.10. Lepu Medical Technology

LIST NOT EXHAUSTIVE

13. Global Fluoroscopy Equipment Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us